Literature DB >> 20482490

Bid stands at the crossroad of stress-response pathways.

G Song1, G G Chen, T Hu, P B S Lai.   

Abstract

Bid, a BH3-only Bcl-2 family member, is proven to be a pivotal molecule for the regulation of tumorigenesis by its multiple functions in promoting apoptosis, survival and proliferation. Growing evidence supports that Bid has double roles with respect to stress-response. In most cases it functions in a truncated form, but the cleavage of Bid may not be an absolute requirement for Bid to be pro-apoptotic. Full-length Bid can also translocate to and activate the mitochondria without cleavage. Bid has emerged as a central player linking death signals through surface death receptors to the core apoptotic mitochondrial pathway. Bid is also involved in DNA damage response, and the phosphorylated Bid may negatively regulate its pro-apoptotic function independent of the BH3 domain. This review surveys recent developments in understanding the molecular mechanisms of Bid activation and its roles in regulating the cross-talk of cell cycle arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482490     DOI: 10.2174/156800910791859515

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  11 in total

1.  Inhibition of Drp1 provides neuroprotection in vitro and in vivo.

Authors:  J Grohm; S-W Kim; U Mamrak; S Tobaben; A Cassidy-Stone; J Nunnari; N Plesnila; C Culmsee
Journal:  Cell Death Differ       Date:  2012-03-02       Impact factor: 15.828

2.  Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells.

Authors:  Qiao Wang; Haoxin Du; Guojun Geng; Huan Zhou; Minying Xu; Hanwei Cao; Bing Zhang; Gang Song; Tianhui Hu
Journal:  Mol Biol Rep       Date:  2014-02-08       Impact factor: 2.316

3.  Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.

Authors:  Faten Merhi; Ruoping Tang; Marion Piedfer; Julie Mathieu; Isabelle Bombarda; Murhaf Zaher; Jean-Pierre Kolb; Christian Billard; Brigitte Bauvois
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

4.  Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway.

Authors:  Chun Hu; Gang Song; Bing Zhang; Zhongchen Liu; Rong Chen; Hong Zhang; Tianhui Hu
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

5.  Laminarin-induced apoptosis in human colon cancer LoVo cells.

Authors:  Chen-Feng Ji; Yu-Bin Ji
Journal:  Oncol Lett       Date:  2014-03-07       Impact factor: 2.967

6.  ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis.

Authors:  S-A Quast; A Berger; J Eberle
Journal:  Cell Death Dis       Date:  2013-10-10       Impact factor: 8.469

7.  Overexpression of BID in thyroids of transgenic mice increases sensitivity to iodine-induced autoimmune thyroiditis.

Authors:  Su He Wang; Yongyi Fan; James R Baker
Journal:  J Transl Med       Date:  2014-06-23       Impact factor: 5.531

8.  KRAS induces lung tumorigenesis through microRNAs modulation.

Authors:  Lei Shi; Justin Middleton; Young-Jun Jeon; Peter Magee; Dario Veneziano; Alessandro Laganà; Hui-Sun Leong; Sudhakar Sahoo; Matteo Fassan; Richard Booton; Rajesh Shah; Philip A J Crosbie; Michela Garofalo
Journal:  Cell Death Dis       Date:  2018-02-13       Impact factor: 8.469

9.  Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.

Authors:  Marion Piedfer; Daniel Dauzonne; Ruoping Tang; Juliette N'Guyen; Christian Billard; Brigitte Bauvois
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

10.  The CNGRC-GG-D(KLAKLAK)2 peptide induces a caspase-independent, Ca2+-dependent death in human leukemic myeloid cells by targeting surface aminopeptidase N/CD13.

Authors:  Sandrine Bouchet; Ruoping Tang; Fanny Fava; Ollivier Legrand; Brigitte Bauvois
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.